Medication info

Rosavel 100 mg (Losartan Potassium)

Prescription medicationTabletOralExpired
Ingredient · strength
Losartan Potassium›100mg / 1 tablet
Manufacturer / importer
Farmgen Science Co., Ltd.
Appearance
White, drop-shaped film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 202002222 · Approved 2020.03.31

This product's status changed to Expired on 2025.03.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of hypertension and kidney disease in patients with type 2 diabetes and hypertension
Who takes it
Adults · Children
Adult dose
This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension — The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses per day, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this drug alone, it may be administered in combination with another antihypertensive drug (e.g., a low-dose diuretic). An additive effect has been observed with concomitant hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension — The usual adult dose is 50 mg of this drug once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No initial dose adjustment is necessary in older adults aged 75 years or younger. For older adults over 75 years, an initial dose of 25 mg of this drug once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance <20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. For patients who may have reduced intravascular circulating volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for Use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years or older who weigh 20 kg or more and less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this drug once daily; it may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily; it may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Ingredients

Manufacturer
Farmgen Science Co., Ltd.

Efficacy & effects

Treatment of hypertension and kidney disease in patients with type 2 diabetes and hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is mainly used for the treatment of hypertension and is particularly helpful in preventing and managing kidney disease in patients with type 2 diabetes accompanied by hypertension. Accordingly, it is useful for effectively controlling blood pressure and preventing deterioration of kidney function. It is used to reduce complications related to hypertension and improve patients' health.

How to take

Adult dose

This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension — The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses per day, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this drug alone, it may be administered in combination with another antihypertensive drug (e.g., a low-dose diuretic). An additive effect has been observed with concomitant hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension — The usual adult dose is 50 mg of this drug once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No initial dose adjustment is necessary in older adults aged 75 years or younger. For older adults over 75 years, an initial dose of 25 mg of this drug once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance <20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. For patients who may have reduced intravascular circulating volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for Use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years or older who weigh 20 kg or more and less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this drug once daily; it may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily; it may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Precautions

This drug should not be used by pregnant women, especially during the second and third trimesters, as it may cause serious harm to the fetus. If pregnancy is confirmed, it must be discontinued immediately, and tests may be needed to assess the health status of the fetus. This drug should not be administered to patients with severe liver or kidney impairment, patients with certain genetic disorders, or those with a history of angioedema. Elderly patients or those with high potassium levels, impaired liver function, heart valve disease, or reduced blood volume should use this drug with caution and require regular check-ups. Dizziness or symptoms of low blood pressure may occur while taking this drug, so caution is advised when driving or operating dangerous machinery. Co-administration with potassium-sparing diuretics or potassium supplements can lead to dangerously elevated potassium levels, so such combinations should be avoided. Caution is also needed when taking this drug with nonsteroidal anti-inflammatory drugs, as it may reduce blood pressure control and worsen kidney function. This drug can affect liver and kidney function, so patients with liver or kidney disease may require dose adjustments and regular monitoring. Rarely, adverse reactions such as angioedema, hepatitis, muscle pain, skin rash, etc. may occur, so if symptoms arise, immediate consultation with a physician is necessary. In cases of overdose, hypotension and changes in heart rate may occur, and emergency treatment may be required, so caution is advised. It is not safe to use this drug in children under six years and those with severe renal impairment. This drug is not recommended for women who are pregnant or breastfeeding, and if breastfeeding, either avoid taking it or discontinue breastfeeding. When taking this drug, it is important to avoid taking potassium supplements or salt substitutes containing potassium without consulting a physician. This drug must be stored out of reach of children and transferring it to another container should be avoided to prevent quality degradation or accidents.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • muscle cramps
  • back pain
  • leg pain
  • dizziness
  • congestion
  • upper respiratory infection
Show 124 more
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness/fatigue
  • edema/swelling
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • peeling of palm skin
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • arm pain
  • hip pain
  • joint swelling
  • knee pain
  • muscle weakness
  • arthralgia
  • arthritis
  • fibromyalgia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory attenuation
  • decreased libido
  • memory impairment
  • migraine
  • hyperesthesia
  • paresthesia
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremors
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reaction
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • ocular burning and pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • vision decline
  • erectile dysfunction
  • nocturia
  • polyuria
  • urinary tract infection
  • vascular edema
  • vasculitis
  • anaphylaxis-like syndrome
  • liver dysfunction
  • hepatitis
  • malaise
  • thrombocytopenia
  • myalgia
  • weakness
  • elevated creatine kinase
  • rhabdomyolysis
  • dry cough
  • erythematous skin
  • hyperkalemia
  • hyponatremia
  • increased ALT
  • increased BUN
  • elevated serum creatinine
  • decreased hemoglobin
  • decreased hematocrit
  • elevated liver enzymes
  • increased serum bilirubin
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular extrasystole
  • arrhythmia
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a sealed container. Additionally, it is important to store it at room temperature between 1 and 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

White, drop-shaped film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.